Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Cannabis and Opioid Use Disorder

Shanna Babalonis, PhD · with National Institute on Drug Abuse (NIDA) · NCT05729932

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
15
US sites recruiting
1
Study start
September 10, 2024
Record last updated
June 18, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

Being studied: Inhaled vaporized cannabis; Intransal opioid

Conditions: Opioid Use Disorder

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Current opioid use disorder

Exclusion Criteria

  • Current medical conditions that require medical management

Recruiting US locations

  • Center on Drug and Alcohol Research

    Lexington, KY 40508

    Site contact: Paul Nuzzo, MA · 859-323-0002 · pnuzz2@email.uky.edu

Study contacts (from the official record)

  • Paul Nuzzo, MA · 859-323-0002 · pnuzz2@email.uky.edu
Cannabis and Opioid Use Disorder (NCT05729932) | Bored Studies